Passardi A, Sullo FG, Bittoni A, Matteucci L, et al. CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cance BMC Cancer 2025 Nov 22. doi: 10.1186/s12885-025-15371.
PMID: 41275134